Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The best revascularization strategy for patients with both acute ST-elevation myocardial infarction (STEMI) and multivessel coronary disease (MVD) is still debatable. We aimed to compare the outcomes of multivessel revascularization (MVR) with those of culprit-only revascularization (COR). Methods: A cohort of 215 consecutive patients who had received primary angioplasty for STEMI and MVD were divided into two groups according to whether angioplasty had been also performed for a stenotic nonculprit artery. The primary endpoint was one-year major adverse cardiac events defined as a composite of cardiac death, recurrent myocardial infarction, or any repeat revascularization. Results: One-year major adverse cardiac events were not significantly different between MVR (n = 107) and COR (n = 108) groups. However, the one-year composite hard endpoint of cardiac death or recurrent myocardial infarction was notably increased in the MVR group compared to the COR group (20.0% vs. 8.9%, p = 0.024). In subgroup analysis, the hard endpoint was significantly more frequent in the immediate than in the staged MVR subgroup (26.6% vs. 9.8%, p = 0.036). The propensity score-matched cohorts confirmed these findings. Conclusions: In patients with STEMI and MVD, MVR, especially immediate MVR with primary percutaneous intervention, was not beneficial and led to worse outcomes. Therefore, we conclude that COR or staged MVR would be better strategies for patients with STEMI and MVD.
Abstract
Background/Aims: The best revascularization strategy for patients with both acute ST-elevation myocardial infarction (STEMI) and multivessel coronary disease (MVD) is still debatable. We aimed to compare the outcomes of multivessel revascularization (MVR) with those of culprit-only revascularization (COR). Methods: A cohort of 215 consecutive patients who had received primary angioplasty for STEMI and MVD were divided into two groups according to whether angioplasty had been also performed for a stenotic nonculprit artery. The primary endpoint was one-year major adverse cardiac events defined as a composite of cardiac death, recurrent myocardial infarction, or any repeat revascularization. Results: One-year major adverse cardiac events were not significantly different between MVR (n = 107) and COR (n = 108) groups. However, the one-year composite hard endpoint of cardiac death or recurrent myocardial infarction was notably increased in the MVR group compared to the COR group (20.0% vs. 8.9%, p = 0.024). In subgroup analysis, the hard endpoint was significantly more frequent in the immediate than in the staged MVR subgroup (26.6% vs. 9.8%, p = 0.036). The propensity score-matched cohorts confirmed these findings. Conclusions: In patients with STEMI and MVD, MVR, especially immediate MVR with primary percutaneous intervention, was not beneficial and led to worse outcomes. Therefore, we conclude that COR or staged MVR would be better strategies for patients with STEMI and MVD.
참고문헌 (33)
- Keeley EC, "Primary coronary intervention for acute myocardial infarction", JAMA, 291, pp.736~739 (2004)
- Muller DW, "Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group", Am Heart J, 121(4 Pt 1), pp.1042~1049 (1991)
- Jaski BE, "Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease", Am Heart J, 124, pp.1427~1433 (1992)
- Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), "ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation", Eur Heart J, 33, pp.2569~2619 (2012)
- O’Gara PT, "2013 ACCF", AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation, Circulation, pp.2013, 127[DOI]
- Patel MR, "ACCF", SCAI, AATS, pp.AHA, ASNC 2009 appropriateness criteria for coronary revascularization: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography[DOI]
- Widimsky P, "Reperfusion therapy for ST elevation acute myocardial infarction in Europe:description of the current situation in 30 countries", Eur Heart J, 31, pp.943~957 (2010)
- Di Mario C, "Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study", Int J Cardiovasc Intervent, 6, pp.128~133 (2004)
- Khattab AA, "Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction: a single-center experience", Clin Res Cardiol, 97, pp.32~38 (2008)
- Qarawani D, "Culprit only versus complete coronary revascularization during primary PCI", Int J Cardiol, 123, pp.288~292 (2008)
- Politi L, "A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up", Heart, 96, pp.662~667 (2010)
- Corpus RA, "Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction", Am Heart J, 148, pp.493~500 (2004)
- Wald DS, "Randomized trial of preventive angioplasty in myocardial infarction", N Engl J Med, 369, pp.1115~1123 (2013)
- Anderson JL, "ACC", AHA 2007 guidelines for the management of patients with unstable angina, American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina, pp.Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine, J Am Coll Cardiol[DOI]
- Morrow DA, "TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy", Circulation, 102, pp.2031~2037 (2000)
- Austin PC, "Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies", Pharm Stat, 10, pp.150~161 (2011)
- Grines CL, "Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction: the TAMI Study Groups", Circulation, 80, pp.245~253 (1989)
- Gibson CM, "Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction: the TIMI Study Group. Thrombolysis in myocardial infarction", J Am Coll Cardiol, 34, pp.974~982 (1999)
- Goldstein JA, "Multiple complex coronary plaques in patients with acute myocardial infarction", N Engl J Med, 343, pp.915~922 (2000)
- Nath A, "Multivessel coronary angioplasty early after acute myocardial infarction", J Am Coll Cardiol, 16, pp.545~550 (1990)
- Chen LY, "In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction", Am J Cardiol, 95, pp.349~354 (2005)
- Cavender MA, "Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)", Am J Cardiol, 104, pp.507~513 (2009)
- Toma M, "Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction:insights from the APEX-AMI trial", Eur Heart J, 31, pp.1701~1707 (2010)
- Pijls NH, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)study", J Am Coll Cardiol, 56, pp.177~184 (2010)
- Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention", N Engl J Med, 360, pp.213~224 (2009)
- Ntalianis A, "Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction", JACC Cardiovasc Interv, 3, pp.1274~1281 (2010)
- Tonino PA, "Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation", J Am Coll Cardiol, 55, pp.2816~2821 (2010)
- Legalery P, "One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty", Eur Heart J, 26, pp.2623~2629 (2005)
- D’Agostino RB Jr, "Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group", Stat Med, 17, pp.2265~2281 (1998)
- Brener SJ, "The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion : insights from the Global Utilization of Strategies To open Occluded arteries(GUSTO)V trial", Am Heart J, 150, pp.89~93 (2005)
- Morrow DA, "Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3", JAMA, 286, pp.1356~1359 (2001)
- Thune JJ, "Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty", Circulation, 112, pp.2017~2021 (2005)
- 조현수, "Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis", Korean Circulation Journal, 41(12), pp.718~725 (2011), 대한심장학회